• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入性类固醇的皮肤不良反应。

Cutaneous adverse effects of inhaled steroids.

出版信息

Prescrire Int. 2007 Jun;16(89):112-3.

PMID:17590907
Abstract

(1) Oral steroids can damage the skin. Cutaneous thinning and bruising have also been reported with inhaled steroids. (2) A randomised double-blind placebo-controlled trial of inhaled triamcinolone in chronic obstructive pulmonary disease provides useful data on the frequency of such effects. (3) The frequency of bruising was 11.2% with the steroid and 3.7% with placebo, while delayed wound healing occurred in respectively 2.4% and 0.5% of patients. These cutaneous adverse effects were dose-dependent and increased with age. (4) The inhaled route does not prevent steroid adverse effects occurring at a distance from the airways. This is one more reason for using the minimal effective dose of inhaled steroids, especially in older patients.

摘要

(1) 口服类固醇会损害皮肤。吸入性类固醇也会导致皮肤变薄和瘀伤。(2) 一项关于吸入曲安奈德治疗慢性阻塞性肺疾病的随机双盲安慰剂对照试验,提供了关于此类影响发生频率的有用数据。(3) 使用类固醇的患者瘀伤发生率为11.2%,使用安慰剂的患者为3.7%,而伤口愈合延迟分别发生在2.4%和0.5%的患者中。这些皮肤不良反应具有剂量依赖性,并随年龄增长而增加。(4) 吸入途径并不能防止气道以外部位出现类固醇不良反应。这是使用最小有效剂量吸入性类固醇的又一个原因,尤其是在老年患者中。

相似文献

1
Cutaneous adverse effects of inhaled steroids.吸入性类固醇的皮肤不良反应。
Prescrire Int. 2007 Jun;16(89):112-3.
2
[Inhalational corticosteroids in COPD. THe ISOLDE Study (Inhaled Steroids in Obstructive Lung Disease in Europe)].
Internist (Berl). 2001 Jul;42(7):1050-2.
3
Ethics of placebo controlled studies of inhaled steroids for COPD.慢性阻塞性肺疾病吸入性类固醇药物安慰剂对照研究的伦理学
Thorax. 2004 Jun;59(6):539; author reply 539-40.
4
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.慢性阻塞性肺疾病的药物治疗:一项混合治疗比较的荟萃分析。
Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.
5
Adverse skin reactions to inhaled corticosteroids.吸入性糖皮质激素引起的皮肤不良反应。
Expert Opin Drug Saf. 2002 Nov;1(4):325-9. doi: 10.1517/14740338.1.4.325.
6
Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.长期使用吸入性糖皮质激素与慢性阻塞性肺疾病患者肺炎风险:一项荟萃分析
Arch Intern Med. 2009 Feb 9;169(3):219-29. doi: 10.1001/archinternmed.2008.550.
7
Inhaled steroids for chronic obstructive pulmonary disease--where are we now?用于慢性阻塞性肺疾病的吸入性类固醇——我们现在处于什么阶段?
N Z Med J. 2000 Aug 11;113(1115):337-8.
8
Inhaled triamcinolone and chronic obstructive pulmonary disease.吸入性曲安奈德与慢性阻塞性肺疾病
N Engl J Med. 2001 May 17;344(20):1553; author reply 1554-6.
9
Corticosteroids: neuropsychiatric effects in children and adolescents. Neuropsychiatric adverse effects, even when inhaled.
Prescrire Int. 2009 Jun;18(101):123.
10
Inhaled corticosteroids in obstructive airway disease.阻塞性气道疾病中的吸入性糖皮质激素
Respir Care. 2007 Jul;52(7):852-8.